Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Pipeline for inferring tissues from liquid biopsy data

    In many cases, solid tissue biopsies cannot be performed in humans. If a liquid biopsy is performed on humans, we can assess microRNA, RNA, and DNA in the blood. These microRNA, RNA, and DNA presumably came from solid tissues. I have read that it can be inferred which tissues these microRNA, RNA, and DNA likely came from.

    If that is true, what is the general pipeline for such an analysis (at a high level, i.e. for a non expert)? Are there any resources for a newbie interested in this type of research to better understand this pipeline?

  • #2
    For solid tissue analysis, you have the assumption, that your observed xNA (miroRNA, RNA, DNA, etc.) is derived from one origin showing a certain 'fingerprint'. Meaning that your observation is depending on the tissue type. In such a case, you can use e.g. biogps.org datasets to perform a GSEA to obtain/rank the tissues which fit best to your data set.

    In your blood or other liquid sample, you have a mixture of xNAs produced in various tissues. The "simple" dependency assumption is not working.
    I fear it's not as easy to trace back from which tissue a certain amount a feature is produced. Especially, since you cannot deduce directly from an observed tissue-related expression/feature that this tissue is able to secrete the xNA into the blood.

    There might be certain microRNAs / RNAs which are only produced in certain tissue(s) exclusively (for instance MUP4 in mouse lacrimal glands).

    You might start with a simple likelihood model for each feature from which tissue it might came from.

    Best,

    Michael

    Comment


    • #3
      Thank you for your response. I can certainly write some scripts that use likelihood models to estimate which tissue each feature may be derived from.

      As a confirmation, it seems there are no software or published pipelines already available for inferring which tissues xNA from blood samples are likely derived from?

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Strategies for Sequencing Challenging Samples
        by seqadmin


        Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
        03-22-2024, 06:39 AM
      • seqadmin
        Techniques and Challenges in Conservation Genomics
        by seqadmin



        The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.

        Avian Conservation
        Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...
        03-08-2024, 10:41 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Yesterday, 06:37 PM
      0 responses
      10 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, Yesterday, 06:07 PM
      0 responses
      10 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 03-22-2024, 10:03 AM
      0 responses
      51 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 03-21-2024, 07:32 AM
      0 responses
      67 views
      0 likes
      Last Post seqadmin  
      Working...
      X